Deutsche Bank’s Gossamer Bio GOSS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$188K Sell
13,831
-2,493
-15% -$55.7K ﹤0.01% 3290
2026
Q1
$431K Buy
16,324
+270
+2% +$33.9K ﹤0.01% 2651
2025
Q4
$3.98M Buy
16,054
+67
+0.4% +$15.3K ﹤0.01% 1415
2025
Q3
$3.36M Sell
15,987
-12,281
-43% -$2.17M ﹤0.01% 1486
2025
Q2
$2.78M Buy
28,268
+1,859
+7% +$162K ﹤0.01% 1521
2025
Q1
$2.32M Hold
26,409
– – ﹤0.01% 1651
2024
Q4
$1.92M Hold
26,409
– – ﹤0.01% 1887
2024
Q3
$2.09M Sell
26,409
-21,187
-45% -$1.63M ﹤0.01% 1712
2024
Q2
$3.43M Hold
47,596
– – ﹤0.01% 1379
2024
Q1
$4.49M Hold
47,596
– – ﹤0.01% 1316
2023
Q4
$3.46M Buy
+47,596
New +$2.81M ﹤0.01% 1407
2023
Q3
– Sell
-2,025
Closed -$194K – 3752
2023
Q2
$194K Sell
2,025
-588
-23% -$58.6K ﹤0.01% 2892
2023
Q1
$263K Buy
2,613
+130
+5% +$19.9K ﹤0.01% 2870
2022
Q4
$431K Buy
2,483
+98
+4% +$64.5K ﹤0.01% 2533
2022
Q3
$2.29M Buy
2,385
+1,898
+390% +$1.88M ﹤0.01% 1560
2022
Q2
$326K Sell
487
-13
-3% -$8.06K ﹤0.01% 2861
2022
Q1
$347K Sell
500
-263
-34% -$203K ﹤0.01% 2958
2021
Q4
$690K Buy
763
+16
+2% +$15.2K ﹤0.01% 2638
2021
Q3
$751K Buy
747
+200
+37% +$147K ﹤0.01% 2787
2021
Q2
$356K Buy
547
+23
+4% +$16K ﹤0.01% 3448
2021
Q1
$388K Sell
524
-41
-7% -$33.1K ﹤0.01% 3256
2020
Q4
$437K Sell
565
-1,764
-76% -$1.39M ﹤0.01% 2996
2020
Q3
$2.31M Sell
2,329
-2,035
-47% -$2.16M ﹤0.01% 1656
2020
Q2
$4.54M Buy
4,364
+4,185
+2,338% +$4.21M ﹤0.01% 1346
2020
Q1
$146K Sell
179
-10
-5% -$10.4K ﹤0.01% 3096
2019
Q4
$235K Buy
189
+38
+25% +$61.2K ﹤0.01% 3118
2019
Q3
$201K Sell
151
-94
-38% -$150K ﹤0.01% 3195
2019
Q2
$431K Buy
245
+69
+39% +$106K ﹤0.01% 3369
2019
Q1
$303K Buy
+176
New +$294K ﹤0.01% 3753

Other funds holding GOSS

Deutsche Bank's GOSS Position: Q2 2026 in Review

Deutsche Bank reduced its Gossamer Bio (GOSS) stake by 15% in Q2 2026, selling an estimated $55.7K and leaving 13,831 shares worth $188K. The position accounts for ﹤0.01% of the portfolio, ranked #3290.

Deutsche Bank first reported a position in GOSS in Q1 2019 and has held it in 29 quarters since. The position peaked at $4.54M in Q2 2020. 166 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

  • Deutsche Bank held 13,831 shares of Gossamer Bio worth $188K as of Q2 2026.
  • Deutsche Bank sold 2,493 Gossamer Bio shares in Q2 2026, an estimated $55.7K.
  • Gossamer Bio made up ﹤0.01% of Deutsche Bank's portfolio in Q2 2026, its #3290 holding.
  • Deutsche Bank first reported a position in Gossamer Bio in Q1 2019 and has held it in 29 quarters since.
  • Deutsche Bank's Gossamer Bio position peaked at $4.54M in Q2 2020.
  • 166 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.